|Previous Section||Index||Home Page|
Mr. Amess: To ask the Secretary of State for Health (1) whether the letter she sent to the pro-choice meeting chaired by Baroness Gould on 26 October represents Government policy; if she will place a copy of the letter in the Library; and if she will make a statement; 
(2) what discussions she had with (a) ministerial colleagues and (b) officials in her Department before sending her letter to the pro-choice meeting chaired by Baroness Gould on 26 October; and if she will make a statement; 
Caroline Flint: The letter was sent in response to an invitation to attend the abortion rights public meeting Defend the limitDefend a woman's right to choose", held at the House of Lords on 26 October 2005. The letter, which was sent by a departmental official on 14 October 2005, stated
Ms Rosie Winterton:
The table shows the estimated average waiting time from general practitioner writtenreferral to first outpatient appointment with a consultant psychiatrist within Coventry primary care trust (PCT) between September 2004 to September 2005 (provider based).
20 Dec 2005 : Column 2726W
|Median wait (weeks)|
Ms Rosie Winterton: The Secretary of State has delegated the majority of her appointments functions to the National Health Service Appointments Commission. The commission intends to make information about the public appointments it makes available on its website www.appointments.org.uk in the early spring next year.
Ms Rosie Winterton [holding answer 8 December 2005]: Quality assurance is an integral part of all screening programmes. Quality assurance standards have been developed and piloted by the UK National Screening Committee's national screening programme for sight threatening retinopathy. A full list of the quality assurance standards can be found on the National Screening Programme's website at: www.nscretinopathy.org.uk. Screening programme managers are responsible for ensuring that programmes meet overall quality requirements. Strategic health authorities are responsible for ensuring action is taken on quality assurance recommendations.
Jane Kennedy: As with all marketed medicines, the safety of mifepristone, an antiprogestogenic steroid that is used for the medical termination of intra-uterine pregnancy, is continuously monitored by the Medicines and Healthcare products Regulatory Agency (MHRA).
Mifepristone was first authorised in the United Kingdom as a prescription only medicine for use under specialist care in July 1991. This followed advice from the then Committee on Safety of Medicines. Since 1991, the safety of mifepristone has been monitored through review of reports of suspected adverse drug reactions and through periodic safety reports submitted by the manufacturer. Following new advice from the US PDA,
20 Dec 2005 : Column 2727W
where this product is used in combination with another medicine that is not licensed for this purpose in the UK, serious adverse reactions, including cases of serious bacterial infection, associated with mifepristone have been reviewed. The regulatory authorities within Europe, including the UK, did not identify any new safety issues as a consequence of this review.
Mr. Lansley: To ask the Secretary of State for Health how many people are on secondment from other organisations to her Department; and which organisations they have been seconded from in each case. 
Steve Webb: To ask the Secretary of State for Health how many situation reports have been delivered to her Department from local NHS bodies in each of the last five years; what the frequency of such reports was; and what issues were covered. 
Mr. Byrne: Daily Situation Reports (SitReps) are collected from acute trusts on weekdays during the winter months on an exception basis. They are required if any of the following operational problems occur:
|Daily SitReps||Weekly SitReps|
Mr. Amess: To ask the Secretary of State for Health what the proportion of smokers are aged (a) 16 and under, (b) 17 to 24, (c) 25 to 30, (d) 31 to 40 and (e) over 40 years, broken down by sex; and what the equivalent figures were in (i) 1976, (ii) 1979, (iii) 1983, (iv) 1987, (v) 1992, (vi) 1997 and (vii) 2000. 
Estimates of the prevalence of smoking among adultsaged 16 and over are obtained from the general household survey. Although the GHS covers Great Britain, the data presented here are for England only.
|1724||2530||3140||Over 40||All adults aged 17 and over|
|All||1619||2024||2534||3549||5059||60 and over|
|Boy regular smoker||11||13||7||7||9||9||8||10|
|Girls regular smoker||11||13||12||9||11||10||11||13|
|Total regular smoker||11||13||10||8||10||10||10||12|
|Boy regular smoker||11||9||8||9||8||9||7||7|
|Girls regular smoker||15||12||10||12||11||11||11||10|
|Total regular smoker||13||11||9||10||10||10||9||9|
Table 1. We have been able to provide prevalence data for ages 1724, 2530, 2140, over 40 and all adults aged 17 and over, for years 1992, 2000 and 2003 using the general household survey. We have been unable to provide data for the above age groups for years 1976, 1979, 1983 and 1987.
Table 2. As we have been unable to provide all yearsrequested in the PQ, we have included smoking prevalence (based on GHS tables) for a range of other years (1980, 1982, 1984, 1986, 1988, 1990, 1992, 1994, 1996, 1998, 2000, 2001, 2002 and 2003). However, this is not readily available in the age groups requested. Instead the data is grouped by those aged 1619, 2024, 2534, 3549, 5059, 60 and over and all ages 16 and over.
Table 3. The PQ asks for data on those aged under 16. The closest smoking prevalence data for children we are able to provide is for pupils in school years seven-11, where the majority of students will be aged 1115. However, the only exact year that we can provide data for is 1992 and 2000. Nonetheless, we have provided prevalence figures in close proximity to the years requested (1982, 1984, 1986, 1988, 1990, 1992, 1993, 1994, 1996, 1998, 2000, 2001, 2002, 2003 and 2004).
Mr. Amess: To ask the Secretary of State for Healthwhat discussions (a) Ministers and (b) officials had with (i) Action on Smoking and Health and (ii)FOREST about part I of the Health Bill; and if she will make a statement. 
Caroline Flint: Since publication of the Health Bill on 27 October 2005 there have been no formal discussions with Action on Smoking and Health or FOREST at either ministerial level or official level.
|Next Section||Index||Home Page|